Intellectus Partners LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Intellectus Partners LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,055 shares of the medical equipment provider’s stock after acquiring an additional 1,510 shares during the quarter. Intellectus Partners LLC’s holdings in Intuitive Surgical were worth $2,708,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ISRG. Rossmore Private Capital raised its stake in Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after acquiring an additional 20 shares during the period. Activest Wealth Management boosted its position in Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the period. Vertex Planning Partners LLC boosted its position in Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 21 shares during the period. Accredited Investors Inc. increased its stake in shares of Intuitive Surgical by 2.0% in the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after purchasing an additional 21 shares in the last quarter. Finally, SPC Financial Inc. increased its stake in shares of Intuitive Surgical by 1.3% in the third quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, SVP Mark Brosius sold 4,500 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 37,261 shares of company stock valued at $19,690,721 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts recently commented on ISRG shares. Raymond James Financial upped their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Argus reduced their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. The Goldman Sachs Group reissued a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a report on Friday, January 9th. Royal Bank Of Canada increased their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 17th. Finally, Sanford C. Bernstein raised their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

Intuitive Surgical Trading Down 1.3%

Shares of Intuitive Surgical stock opened at $490.16 on Friday. The company’s 50-day moving average price is $521.64 and its 200-day moving average price is $512.05. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The company has a market cap of $174.07 billion, a price-to-earnings ratio of 62.12, a PEG ratio of 3.83 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.